Systemic lymphoma is a very common cancer in dogs, but the cutaneous form is quite rare. Current statistics suggest that cutaneous lymphoma accounts for only about 5% of canine lymphoma cases. The disease can present in a variety of lesions, including ulcers, nodules, red patches, and areas of hair loss and skin scaling. Because not very much is known about canine cutaneous lymphoma, there are no standard treatment protocols and the prognosis is poor.

Cutaneous histiocytosis is an uncommon condition in dogs. It is a non-cancerous increase in the number of reactive cells (histiocytes) caused by an immune system dysfunction. It generally manifests as multiple bumps and nodules confined to the dog’s skin. The clinical signs, diagnosis, and treatment of this condition are explained in this handout.

A cutaneous histiocytoma is a common benign (harmless) tumor of the skin in dogs, typically younger ones. Their development, appearance, diagnosis, and treatment are explained in this handout.

Chondrosarcomas arise from cartilage, which is a connective tissue primarily found where bones meet with joints, as well as at other locations in the body such as the nasal cavity, and ribs. Chondrosarcoma is the second-most common primary bone tumor in dogs. Canine chondrosarcoma most commonly affects the flat bones of the body, such as the ribs, skull, nasal cavity, and pelvis, although the limbs can also be affected. Aggressive surgical removal is typically recommended, although radiation therapy may also be used, depending on location of tumor. Metastasis may occur but is relatively uncommon.

Chemotherapy is the therapeutic use of chemical agents to destroy or inhibit the growth and division of cancer cells. Usually, chemotherapy is used when tumors are widespread or when there is significant or immediate risk of spread from the primary location. It is often used following the surgical removal of tumors. In some cases, chemotherapy is started prior to surgery. The side effects of chemotherapy are related to the effects of chemotherapy on normal -as well as cancerous- cells. The principal goal of cancer care in pets is to provide cancer control without reducing quality of life.